NCT06875869 Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients
| NCT ID | NCT06875869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Cervicogenic Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-01-02 |
| Primary Completion | 2025-09-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2025-01-02 with a primary completion date of 2025-09-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to determine the effects of Jones and Ischemic compression technique on pain, range of motion and disability in patients with cervicogenic headache. Cervicogenic headache is a distinctive type of secondary headache where the pain originates from structures in the neck or cervical spine and radiates to the head. Trigger point release has been associated with decrease in symptoms of patients with cervicogenic headache. This study will be a randomized clinical trial with the sample size of 32 patients. Participants will be randomly allocated into two groups: Group A and Group B. The setting of the study will be Bahawal Victoria Hospital, Bahawalpur. Group A will receive Jones technique of trigger points of the upper trapezius and sternocleidomastoid muscle while Group B will receive ischemic compression of the trigger points of the upper trapezius and sternocleidomastoid muscle. Patients of both groups will receive two treatment sessions per week for 6 weeks. Both groups will receive hot pack for 10 minutes, TENS for 15 minutes and strengthening exercises for deep neck flexors (chin tuck and head raise with ten repetitions of 10-second duration, with a 10-second rest interval between each contraction) as baseline treatment protocol. NPRS, HDI and FRT will be used as outcome measure tools. Data will be analyzed using SPSS version 25.0 with the p-value of \<0.05 taken as significant difference.
Eligibility Criteria
Inclusion Criteria: * Both males and females * 25-35 years of age * Individuals satisfying the Cervicogenic Headache criteria * Positive Simon's criteria for trigger points Exclusion Criteria: * primary headaches (i.e., migraine, tension type headache) * bilateral headache * Presence of any red flags * cervical spinal stenosis * evidence of central nervous system involvement * prior surgery to the head or neck
Contact & Investigator
Ghulam Fatima, PHD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06875869 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 35 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06875869 currently recruiting?
Yes, NCT06875869 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06875869 trial being conducted?
This trial is being conducted at Bahawalpur, Pakistan.
Who is sponsoring the NCT06875869 clinical trial?
NCT06875869 is sponsored by Riphah International University. The principal investigator is Ghulam Fatima, PHD* at Riphah International University. The trial plans to enroll 32 participants.